Gene therapy researchers at The Children’s Hospital of Philadelphia have produced a bioengineered decoy that by fooling the immune system prevents it from undermining the benefits delivered by a corrective gene. The decoy could offer a new treatment for genetic diseases while advancing the broader field of gene therapy if the approach succeeds in humans.
